Working… Menu
Trial record 6 of 15 for:    oxi

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial (OXI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02648464
Recruitment Status : Completed
First Posted : January 7, 2016
Last Update Posted : June 9, 2020
Finnish Foundation for Cardiovascular Research
Orion Corporation, Orion Pharma
Aarne Koskelo Foundation
Finnish Cultural Foundation
Information provided by (Responsible Party):
Otto Hartman, Helsinki University Central Hospital